Sponsored By

Medtech's Big Market Movers (Edwards)

Edwards Lifesciences The Sapien transcatheter heart valve, pictured above, that Edwards Lifesciences introduced to the market after winning FDA approval in 2011 helped drive the company's business performance higher.

April 6, 2015

1 Min Read
Medtech's Big Market Movers (Edwards)

Edwards Lifesciences

sapien_edwards.png

The Sapien transcatheter heart valve, pictured above, that Edwards Lifesciences introduced to the market after winning FDA approval in 2011 helped drive the company's business performance higher.

Last year, the California company's share price jumped 94%, to $127.38 from $65.76 at the end of 2013. As a result, the company added $6.4 billion to its market cap.

                     

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like